FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

703674001: Dapagliflozin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3008942010 Dapagliflozin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3009235014 Dapagliflozin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dapagliflozin (substance) Is a Sodium glucose cotransporter subtype 2 inhibitor true Inferred relationship Some
Dapagliflozin (substance) Has disposition (attribute) Sodium glucose cotransporter subtype 2 inhibitor (disposition) true Inferred relationship Some
Dapagliflozin (substance) Is a Substance with ether structure true Inferred relationship Some
Dapagliflozin (substance) Is a Drug or medicament (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Dapagliflozin propanediol Is a False Dapagliflozin (substance) Inferred relationship Some
Product containing dapagliflozin (medicinal product) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 1
Dapagliflozin-containing product in oral dose form Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 1
Dapagliflozin propanediol Is modification of (attribute) True Dapagliflozin (substance) Inferred relationship Some
Product containing only dapagliflozin (medicinal product) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 1
Product containing only dapagliflozin in oral dose form (medicinal product form) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 1
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Dapagliflozin (substance) Inferred relationship Some 1
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Dapagliflozin (substance) Inferred relationship Some 1
Product containing dapagliflozin and metformin and saxagliptin (medicinal product) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 3
Product containing only dapagliflozin and metformin and saxagliptin (medicinal product) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 3
Product containing only dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 3
Dapagliflozin- and metformin- and saxagliptin-containing product in oral dose form Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 3
Dapagliflozin (as dapagliflozin propanediol) 10 mg oral tablet Has basis of strength substance (attribute) True Dapagliflozin (substance) Inferred relationship Some 1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Dapagliflozin (substance) Inferred relationship Some 1
Allergy to dapagliflozin Causative agent True Dapagliflozin (substance) Inferred relationship Some 1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Dapagliflozin (substance) Inferred relationship Some 2
Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet Has basis of strength substance (attribute) True Dapagliflozin (substance) Inferred relationship Some 2
Product containing dapagliflozin and metformin (medicinal product) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 2
Product containing dapagliflozin and metformin in oral dose form (medicinal product form) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 2
Product containing only dapagliflozin and metformin (medicinal product) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 2
Dapagliflozin and metformin only product in oral dose form Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 2
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Dapagliflozin (substance) Inferred relationship Some 2
Product containing only dapagliflozin and saxagliptin (medicinal product) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 2
Product containing dapagliflozin and saxagliptin in oral dose form (medicinal product form) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 2
Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 2
Dapagliflozin- and saxagliptin-containing product Has active ingredient True Dapagliflozin (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start